Skip to main content

A white circular-spot pattern of iridian atrophy associated with Varicella-zoster virus and Toxoplasma gondii coinfection: a case report

Abstract

Background

We report a case of white circular spots of iridian atrophy, which we will call “polka dots” pattern, as a rare ophthalmological finding associated with uveitis secondary to varicella-zoster virus and Toxoplasma gondii coinfection in a male patient in Bogotá, Colombia.

Case presentation

We present de case of a 53-year-old Colombian male patient with a diagnosis of anterior uveitis in his left eye due to varicella-zoster virus and Toxoplasma gondii coinfection documented by polymerase chain reaction analysis. He presented with multiple areas of superficial white circular spots of iridian atrophy in 360º, some with deeper atrophy where the stroma fibers were visualized and only a small punctate defect of transillumination was evident. This rare pattern of iridian atrophy has not been previously described in cases of uveitis in the literature.

Conclusions

This is the first case reporting the findings of superficial “polka dots” pattern iridian atrophy in 360° secondary to anterior uveitis due to the coinfection of a virus and a parasite. The identification of similar clinical cases may lead to early initiation of systemic treatment in these patients.

Peer Review reports

Background

Infectious uveitis is the leading cause of uveitis in Colombia. Toxoplasma gondii (Tg) is the most frequent agent involved in 39.8% of these cases [1], however, ~ 7.5% of ocular toxoplasmosis cases can coexist with other infectious agents, e.g. Mycobacterium tuberculosis, cytomegalovirus (CMV), and varicella-zoster virus (VZV) [2].

Clinical manifestations of ocular toxoplasmosis usually include necrotizing retinochoroiditis, vitritis, optic neuritis, and less frequently, anterior hypertensive uveitis [3]. On the other hand, viral agents uveitis cause a broad clinical spectrum of clinical findings, including ocular hypertension, diffuse stellate keratic precipitates, the presence of iridian atrophy (IA) [4], retinitis, macular edema, scarring, and retinal pigment epithelium hyperplasia [5].

Iris stromal atrophy in uveitis is characterized by sectorial, spiral, or diffuse damage of the iris with transillumination defects, or rarely, massive IA with gross sphincter damage [4]. IA has been associated with iris perfusion disorders [6] and/or viral invasion of the pigment epithelium [4]. Although there are few reports of different infectious etiologies, such as toxocariasis [7] and toxoplasmosis [8] associated with iris heterochromia (Fuchs' heterochromic iridocyclitis), no reports are describing the round circumscribed pattern, which we refer to as the “polka dots” pattern, observed in our patient.

Case presentation

A 53-year-old Colombian male patient with history of ocular toxoplasmosis in his left eye (OS) with signs of posterior uveitis, a retinochoroidal lesion, IgG positive antibodies for Tg and negative results for other diseases such as sarcoidosis, syphilis and tuberculosis, was referred to the uveitis consultation. He was previously treated with Trimetroprim 160 mg + Sulfamethoxazole 800 mg twice daily, Clindamycin 300 mg every 6 h, and Deflazacort 30 mg per day, associated with topical therapy with 1% Prednisolone acetate in a tapering regimen. After 6 weeks the patient presented complete retinochoroiditis improvement. However, anterior chamber cellularity (Tyndall 3 +) persisted and new findings such as multiple areas of superficial circular atrophy in 360º, posterior iris synechiae (Fig. 1) and ocular hypertension were observed. Viral origin due to the presence of IA zones and hypertensive anterior uveitis, was suspected. Therefore, treatment with 1% Prednisolone acetate, 2% Dorzolamide + 0.2% Brimonidine Tartrate + 0.5% Timolol in his OS, and Acyclovir 800 mg five times a day orally for 10 days followed by Acyclovir 800 mg once a day as maintenance dose, was initiated. As a complication, the patient presented cortical opacities and posterior subcapsular cataract of the OS with surgery requirement.

Fig. 1
figure 1

Slit-lamp photography of the anterior segment of the OS. Iris with multiple areas of superficial atrophy of a rounded aspect in 360º, posterior iris synechiae, and cataract

The patient presented reactivation of the inflammatory activity in his OS, despite treatment. Thus, an exhaustive interrogatory and exam was performed, discarding systemic autoimmune disease history and signs. At the ophthalmological evaluation, the patient presented BCVA OD 20/20 and OS 20/30. OD examination was normal. Positive findings in OS were: temporal and nasal conjunctival vessel tortuosity, 0.5 + of anterior chamber cells, increased superficial circular atrophy zones in 360º of the iris, some with deeper atrophy stroma fibers visualization (Fig. 2) and a small punctate defect of transillumination at three hours, dyscoric pupil in medium mydriasis and pseudophakia. IOP was 16/18 mmHg. Fundus observation for OD was normal and OS revealed vitreous syneresis, posterior vitreous detachment, 0.5 + vitreous cells, 0.2 optic disc excavation, and a hypopigmented retinochoroidal scar on the inferior temporal vascular arch.

Fig. 2
figure 2

Slit-lamp photography of the anterior segment of the OS. a. White circular spots iridian superficial atrophy in 360º. b. Some with deeper atrophy where the stroma collagen fibers are visualized (arrowhead)

Laboratories and aqueous humor PCR were requested. They showed VZV IgG 1803.5 IU / ml (positive), CMV IgG 18.6 (positive), herpes simplex virus (HSV) type 2 IgG 16.2 (positive), Tg IgG > 650 (positive), and all IgM tests were negative. Aqueous humor PCR analysis revealed the presence of VZV and Tg genetic material. The multiplex PCR qualitatively used ruled out HSV type 1, HSV type 2, Epstein-Barr virus, CMV, HHV-6 (Human Herpes Virus), HHV-7, and HHV-8 etiologies.

Treatment with oral Pyrimethamine 25 mg + Sulfadoxine 500 mg 3 tablets each 8 days for 6 weeks and Acyclovir 800 mg five times per day for 10 days followed by Acyclovir 800 mg once a day as maintenance dose, 1% Prednisolone acetate in a tapering regimen and topical tropicamide every 8 h until the resolution of inflammation in the anterior chamber was given. After four weeks of therapy, the patient denoted subjective improvement, and resolution of the intraocular inflammation was clinically observed.

Discussion and conclusions

IA may be caused by various types of etiologies such as glaucoma, senility, trauma, surgery, and by hereditary abnormalities. In the literature reviewed, we found two cases of circular spots IA pattern, both diagnosed as vitiligo iridis. The first case was a pediatric patient and the second case was an incidental diagnosis in a 50-year-old man, both with a definite history of smallpox. The lesions were described as multiple grayish-white circular spots with a variable size between 1 to 2 mm on the anterior surface of the iris [9]. This differs from the polka dots pattern observed in our patient since the lesions of our case were bigger and delimitated, however, all cases were unilateral.

Kavitha et al. [10] in 2015 published a series of patients diagnosed with unilateral vitiligo iridis and secondary glaucoma in the same eye with a past medical history of smallpox in their childhood. These patients underwent phacoemulsification, but the iridian defects did not correlate with the atrophy that could be generated after surgery, as in the case of our patient. All three patients presented with pitted scars on their faces [10], nevertheless, we thoroughly examined our patient and found no similar lesions or areas of depigmentation.

In 1973, Spiros et al. described two cases of Afrodescendant woman with sectorial areas of whitish round superficial IA in the proximity of the collarette in both eyes and no transillumination defects. Blood smear analysis revealed anisocytosis and hyperchromic erythrocytes. Hemoglobin electrophoresis confirmed the diagnosis of sickle cell disease [11]. This differs from our patient since he was Hispanic, he did not have sickle cell disease manifestations, and the iris lesions were not around the iridian collarette but predominantly in the periphery with a smaller diameter.

There have been previously reported an association between the VZV viral load in the aqueous humor and the clinical manifestations of VZV anterior uveitis. IA finding was found to be much more severe in a high-viral load group compared with a low-viral load group of patients with VZV anterior uveitis [12].

Some theories about the pathogenesis of IA have been considered over the years. In the case of VZV, the infection seems to be associated with invasion of the pigment epithelium by the virus, an occlusive vasculitis that may produce ischemia or a neurogenic effect [13]. The vasculitis pathogenesis is secondary to a viral invasion of blood vessels from neighboring nerves or an immunogenic mechanism in response to zoster antigens resulting from viral replication in nerves in the iris [14, 15]. In these patients, fluorescein angiography of the anterior segment has shown segmental IA with the corresponding non-perfusion of radial vessels and some micro-neovascularization [6].

Histopathological studies of multiple enucleated eyes following ophthalmic herpes zoster infection showed scarring of the stroma, numerous pigment-laden macrophages, and occasionally proliferation of pigment epithelial cells. These results resemble the observations in ischemic necrosis of the iris in acute angle-closure glaucoma. Therefore, it is hypothesized that the findings described may be secondary to an acute rise in the IOP or as the result of both chronic inflammation and ischemia secondary to vasculitis [14].

Furthermore, the IOP elevation may be due to inflammation of the trabecular meshwork and the accumulation of inflammatory debris from uveitis. The IOP must be monitored at all examinations because it often increases suddenly [16]. This acute and persistent increase may lead to episodes of ischemia that cause IA, which is thought to be one of the factors contributing to the iris depigmentation shown in the case of our patient.

Both large and small arteries can be affected by VZV vasculopathy, and these may result in episodes of ischemic or hemorrhagic strokes [17]. Direct infiltration of the VZV has been found in the walls of the SNC vessels [18, 19]. In the early phase of infection, these viruses can be found in the adventitia, and in later stages, they are often found in the media and intima layers [20]. This suggests infiltration transmurally from the adventitia to the intima, possibly after extending transaxonally to the artery from the ganglion [21].

Tg infection usually affects the retina and choroid in the eye, however, it has also been described in syndromes with Fuchs' heterochromic uveitis etiologies [7], in which the stromal atrophy exposes substantial areas of the iris pigmented epithelium, but unlike the case of our patient without a specific “polka dots” pattern. Anterior segment findings in Tg infections may include granulomatous or stellate keratic precipitates, elevated IOP [22, 23], and complications, such as anterior and posterior synechiae and IA, occur in less than 5% of eyes [24].

In the case we presented here, the question arises of whether there was a summation of atrophy mechanisms of the virus and pathogen, or if the changes in the IOP caused the whitish round superficial atrophy in multiple locations in the iris.

The diagnosis of retinochoroiditis by Tg is clinical, however, in cases such as the previously presented, PCR is a fundamental study to determine appropriate management. The calculated percentages for sensitivity, specificity, positive predictive value, and negative predictive value of PCR in aqueous humor have been described as 91.3%, 98.8%, 98.6%, and 92.4% respectively. The multiplex PCR qualitatively used in our uveitis patients measure the genomic DNA of 8 families of herpes virus: HSV type 1, HSV type 2, VZV, Epstein-Barr virus, CMV, HHV-6, HHV-7, HHV-8, and Tg. [25].

In a study of 66 Colombian patients with uveitis of presumed infectious origin, PCR analysis of aqueous humor and vitreous humor samples suggested that 33.3% were ocular toxoplasmosis and 7.5% were caused by a coinfection. Of this last group, 4.5% corresponded to VZV and Tg co-infections [2].

In a study made with patients clinically diagnosed with active ocular toxoplasmosis, the PCR qualitative analysis in aqueous humor showed to be positive for Tg DNA in 37.21% of the samples and 2.33% of the peripheral blood samples [26]. Nevertheless, PCR positivity for Tg DNA has been found in patients with inactive retinochoroiditis scars. This is thought to happen because latent Tg organisms or their antigens, present in inactive retinal cysts, could be released into the vitreous, causing the uveitis, without any associated foci of active infection or retinal necrosis [27]. We consider that the patient had an active infection by both microorganisms, Tg and VZV, since the response to treatment was favorable by giving a new antiparasitic therapy associated with antiviral therapy.

To the best of our knowledge, this is the first study to report a case of a rare pattern consisting of multiple whitish round superficial IA, we termed a “polka dots” pattern, related to Tg and VZV coinfection uveitis. This manifestation may be associated with multiple physiopathological mechanisms, including ocular hypertension, local vasculitis, and inflammation in the iridian surface. We discarded several differential diagnoses, such as vitiligo, complicated cataract surgery, and hematological diseases, confirming that the cause of the patches is related to the infectious background of our patient. The identification of similar clinical cases may lead to early initiation of systemic treatment in these patients.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and available from the corresponding author on reasonable request.

Abbreviations

Tg:

Toxoplasma gondii

CMV:

Cytomegalovirus

VZV:

Varicella-zoster virus

HHV:

Human herpesvirus

IA:

Iris atrophy

OS:

Left eye

HSV:

Herpes simplex virus

PCR:

Polymerase chain reaction

IOP:

Intraocular pressure

References

  1. De-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya J-M. Clinical patterns of uveitis in two ophthalmology centres in Bogota. Colombia Clin Experiment Ophthalmol. 2009;37:458–66.

    Article  Google Scholar 

  2. de-la-Torre A, Valdés-Camacho J, de Mesa CL, Uauy-Nazal A, Zuluaga JD, Ramírez-Páez LM, et al. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis. 2019;19:91.

  3. Park Y-H, Nam H-W. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol. 2013;51:393.

    Article  Google Scholar 

  4. Chan NS, Chee S. Demystifying viral anterior uveitis: A review. Clin Experiment Ophthalmol. 2019;47:320–33.

    Article  Google Scholar 

  5. Lee JH, Agarwal A, Mahendradas P, Lee CS, Gupta V, Pavesio CE, et al. Viral posterior uveitis. Surv Ophthalmol. 2017;62:404–45.

    Article  Google Scholar 

  6. Gillies WE, Brooks AM. Disorders of perfusion of the anterior segment of the eye. Aust N Z J Ophthalmol. 1996;24:169–87.

    Article  CAS  Google Scholar 

  7. Teyssot N, Cassoux N, Lehoang P, Bodaghi B. Fuchs heterochromic cyclitis and ocular toxocariasis. Am J Ophthalmol. 2005;139:915–6.

    Article  Google Scholar 

  8. Schwab IR. The Epidemiologic Association of Fuchs’ Heterochromie Iridocyclitis and Ocular Toxoplasmosis. Am J Ophthalmol. 1991;111:356–62.

    Article  CAS  Google Scholar 

  9. Shukla B, Srivastava S, Jain S. Unilateral vitiligo iridis. Br J Ophthalmol. 1966;50:436.

    Article  CAS  Google Scholar 

  10. Kavitha S, Patel S, Mohini P, Venkatesh R, Sengupta S. Vitiligo iridis and glaucoma: a rare sequelae of small pox. Eye. 2015;29:1392.

    Article  CAS  Google Scholar 

  11. Galinos S, Rabb MF, Goldberg MF, Frenkel M. Hemoglobin SC disease and iris atrophy. Am J Ophthalmol. 1973;75:421–5.

    Article  CAS  Google Scholar 

  12. Kido S, Sugita S, Horie S, Miyanaga M, Miyata K, Shimizu N, et al. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. Br J Ophthalmol. 2008;92:505–8.

    Article  CAS  Google Scholar 

  13. Chignell A, Easty D. Iris fluorescein photography following retinal detachment and in certain ocular ischaemic disorders. Trans Ophthalmol Soc U K. 1971;91:243.

    CAS  PubMed  Google Scholar 

  14. Naumann G, Donald J, Gass M, Font RL. Histopathology of herpes zoster ophthalmicus. Am J Ophthalmol. 1968;65:533–41.

    Article  CAS  Google Scholar 

  15. Sakai J, Usui Y, Suzuki J, Kezuka T, Goto H. Clinical features of anterior uveitis caused by three different herpes viruses. IntOphthalmol. 2019;39(12):1–11.

    Google Scholar 

  16. Womack LW, Liesegang TJ. Complications of herpes zoster ophthalmicus. Arch Ophthalmol. 1983;101:42–5.

    Article  CAS  Google Scholar 

  17. Teo S, Raha D, Warren D, Hassan A, Monteiro E. Central nervous system–immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke. Int J STD AIDS. 2014;25:683–5.

    Article  CAS  Google Scholar 

  18. Gilden D, Kleinschmidt-DeMasters B, Wellish M, Hedley-Whyte E, Rentier B, Mahalingam R. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5–1995 revisited. Neurology. 1996;47:1441–6.

    Article  CAS  Google Scholar 

  19. Melanson M, Chalk C, Georgevich L, Fett K, Lapierre Y, Duong H, et al. Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology. 1996;47:569–70.

    Article  CAS  Google Scholar 

  20. Nagel M, Traktinskiy I, Azarkh Y, Kleinschmidt-DeMasters B, Hedley-Whyte T, Russman A, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology. 2011;77:364–70.

    Article  CAS  Google Scholar 

  21. Nagel MA, Gilden D. Varicella zoster complications. Curr Treat Options Neurol. 2013;15:439.

    Article  Google Scholar 

  22. London NJ, Hovakimyan A, Cubillan LD, Siverio CD Jr, Cunningham ET Jr. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. Eur J Ophthalmol. 2011;21:811–9.

    Article  Google Scholar 

  23. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109:869–78.

    Article  Google Scholar 

  24. Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008;146:856–65.

    Article  Google Scholar 

  25. Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K, et al. Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology. 2013;120:1761–8.

    Article  Google Scholar 

  26. Santos FFD, Nascimento H, Muccioli C, da Costa DF, Rizzo LV, Commodaro AG, et al. Detection of Toxoplasma gondii DNA in peripheral blood and aqueous humor of patients with Toxoplasmic active focal necrotizing retinochoroiditis using real-time PCR. Arq Bras Oftalmol. 2015;78:356–8.

    Article  Google Scholar 

  27. Novais EA, Commodaro AG, Santos F, Muccioli C, Maia A, Nascimento H, et al. Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood. Br J Ophthalmol. 2014;98:937–40.

    Article  Google Scholar 

Download references

Acknowledgments

Not applicable.

Funding

No funding was received to carry out this study.

Author information

Authors and Affiliations

Authors

Contributions

JMO and ADLT contributed to the conception of the study. JMO, OLRR, MCC, KAR, and ADLT participated in the design of the work. JMO, OLRR, MCC, and KAR drafted the work. Lastly, JMO and ADLT substantively revised it. All the authors approved the manuscript final version.

Corresponding author

Correspondence to Alejandra de-la-Torre.

Ethics declarations

Ethics approval and consent to participate

Approval was granted to us according to the declaration of Helsinki and Law 8430 of 1993.

Consent for publication

Written informed consent was obtained from the patient for the publication of this report and any accompanying images. A copy of the written consent is available for review by the editor of the journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muñoz-Ortiz, J., Rubio-Romero, O.L., Cedeño, M.C. et al. A white circular-spot pattern of iridian atrophy associated with Varicella-zoster virus and Toxoplasma gondii coinfection: a case report. BMC Ophthalmol 20, 479 (2020). https://doi.org/10.1186/s12886-020-01748-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-020-01748-8

Keywords